כניסה 
עקבו אחרינו בפייסבוק מיזופרוסטול - Misoprostol
מתוך ויקירפואה
| מיזופרוסטול - Misoprostol | ||
|---|---|---|
| שמות מסחריים | ®CYTOTEC | |
| קבוצה פרמקולוגית (ATC) | "PROSTAGLANDINS" | |
| שם גנרי | "מיזופרוסטול" (קישור לדף התרופה במאגר משרד הבריאות) |
|
| סל הבריאות | לא כלול | |
התוויות |
For the treatment of duodenal and gastric ulcer. Treatment and prevention NSAID induced ulcers lesions, erosions, while NSAID therapy continues. Use in conjunction with Mifepristone subject to the approval of a committee for the termination of pregnancy according to the Israeli Penal law 1977. Failure of pregnancy in the first trimester : The usage is designated to empty the uterus in a state of failure in the first trimester including pregnancy: when a pregnancy sac was presented in the uterus with no fetus eco, rejected abortion (until week 11+6 and a fetus length of 40 mm) or incomplete abortion. The usage in the product will be done after the location of the sac in the uterus was proven and the diagnosis of pregnancy failure is assured. The usage of the product for this goal is in ambulatory setting. The dosage and route of administration will be similar to the usage of Cytotec in pregnancy termination after the use of Mefigyine. Informed consent and medical monitoring are required. Softening and widening of the cervix for intra-uterine procedures: The usage is designed to soften and widen the cervix to perform intra-uterine procedures such as: abortion, hysteroscopy, insertion of IUD and others, according to clinical decision. The product should be used for this purpose in ambulatory setting. The route of administration (vaginal,sublingual, buccal, oral or rectal) and the dosage is under the decision of the physician
| |
| קיים גם בתכשירים | ARTHROTEC | |
| שם יצרן | PHARMACIA LTD.(FORMERLY SEARLE LTD), UK | |
| שם בעל הרישום | PFIZER PHARMACEUTICALS ISRAEL LTD | |